Sign in
4

Changes in Ownership

Opus Genetics, Inc. Filed Acc 0001140361-14-002177

Options or other derivatives

  • Chief Financial Officer acquired 175,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Jeong Tae Heum · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2014-01-12 Grant or award : show line 1 in the form Stock Option (right to purchase) +175,000 $1.14 2024-01-12 175,000 175,000 D
Loading xslF345X03/doc1.xml…